Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

Bio-Rad Laboratories Stock: Is BIO Underperforming the Healthcare Sector?

With a market cap of $9.5 billion, Bio-Rad Laboratories, Inc. (BIO) operates in the healthcare and life sciences industry. The Hercules, California-based company develops and manufactures a wide range of clinical diagnostics and life science research products, serving markets such as biopharmaceuticals, genomics, proteomics, and food safety.

Companies valued at less than $10 billion are generally considered “mid-cap” stocks and Bio-Rad Laboratories fits this criterion perfectly. Bio-Rad Laboratories is renowned for its pioneering Digital Droplet technology, which offers unmatched precision and sensitivity in quantifying DNA and RNA molecules, setting it apart in both life science research and clinical diagnostics.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.